BACKGROUND: Clinical signs and symptoms of acute human immunodeficiency virus (HIV) infection in infants are not well characterized. METHODS: Serial clinical assessments and HIV PCR assays were conducted in a cohort of children born to HIV-seropositive mothers from birth to 2 years of age. Acute HIV infection visits were defined as those up to 3 months prior to and including the visit at which HIV DNA was first detected. Noninfection visits included all visits at which the child had test results negative for HIV, including the last visit at which a test result negative for HIV DNA was obtained in children who later acquired HIV infection. Differences in the prevalence of symptoms at acute infection versus noninfection visits were determined overall and were stratified by age at infection (<2 months vs. >or=2 months). HIV RNA was measured serially in infected infants and was compared between infants with and infants without symptoms of acute HIV infection. RESULTS: There were 125 acute infection visits (among 56 infants) and 3491 noninfection visits (among 306 infants). Acute HIV infection was associated with rash (odds ratio [OR], 1.8; 95% confidence interval [CI], 1.1-2.8), failure to thrive (OR, 1.9; 95% CI, 1.0-3.5), and lymphadenopathy (OR, 2.5; 95% CI, 1.4-4.8). Acute HIV infection was associated with lymphadenopathy (OR, 2.6; 95% CI, 1.3-5.0) in infants <2 months of age and with pneumonia (OR, 3.2; 95% CI, 1.1-9.3) and dehydration (OR, 6.0; 95% CI, 1.9-18.5) in infants >or=2 months of age. Infant peak viral load and mortality were not associated with symptoms of acute HIV infection. However, infants with symptoms had higher viral levels later in the course of infection than did those without symptoms (P=.05). CONCLUSIONS: Infants may manifest symptoms early during the course of HIV infection, and symptoms of acute HIV infection may correlate with poor viral control. Rash, failure to thrive, lymphadenopathy, pneumonia, and dehydration may signify acute HIV infection in infants.
BACKGROUND: Clinical signs and symptoms of acute human immunodeficiency virus (HIV) infection in infants are not well characterized. METHODS: Serial clinical assessments and HIV PCR assays were conducted in a cohort of children born to HIV-seropositive mothers from birth to 2 years of age. Acute HIV infection visits were defined as those up to 3 months prior to and including the visit at which HIV DNA was first detected. Noninfection visits included all visits at which the child had test results negative for HIV, including the last visit at which a test result negative for HIV DNA was obtained in children who later acquired HIV infection. Differences in the prevalence of symptoms at acute infection versus noninfection visits were determined overall and were stratified by age at infection (<2 months vs. >or=2 months). HIV RNA was measured serially in infected infants and was compared between infants with and infants without symptoms of acute HIV infection. RESULTS: There were 125 acute infection visits (among 56 infants) and 3491 noninfection visits (among 306 infants). Acute HIV infection was associated with rash (odds ratio [OR], 1.8; 95% confidence interval [CI], 1.1-2.8), failure to thrive (OR, 1.9; 95% CI, 1.0-3.5), and lymphadenopathy (OR, 2.5; 95% CI, 1.4-4.8). Acute HIV infection was associated with lymphadenopathy (OR, 2.6; 95% CI, 1.3-5.0) in infants <2 months of age and with pneumonia (OR, 3.2; 95% CI, 1.1-9.3) and dehydration (OR, 6.0; 95% CI, 1.9-18.5) in infants >or=2 months of age. Infant peak viral load and mortality were not associated with symptoms of acute HIV infection. However, infants with symptoms had higher viral levels later in the course of infection than did those without symptoms (P=.05). CONCLUSIONS:Infants may manifest symptoms early during the course of HIV infection, and symptoms of acute HIV infection may correlate with poor viral control. Rash, failure to thrive, lymphadenopathy, pneumonia, and dehydration may signify acute HIV infection in infants.
Authors: R Nduati; G John; D Mbori-Ngacha; B Richardson; J Overbaugh; A Mwatha; J Ndinya-Achola; J Bwayo; F E Onyango; J Hughes; J Kreiss Journal: JAMA Date: 2000-03-01 Impact factor: 56.272
Authors: D Mbori-Ngacha; R Nduati; G John; M Reilly; B Richardson; A Mwatha; J Ndinya-Achola; J Bwayo; J Kreiss Journal: JAMA Date: 2001-11-21 Impact factor: 56.272
Authors: S Emery; S Bodrug; B A Richardson; C Giachetti; M A Bott; D Panteleeff; L L Jagodzinski; N L Michael; R Nduati; J Bwayo; J K Kreiss; J Overbaugh Journal: J Clin Microbiol Date: 2000-07 Impact factor: 5.948
Authors: L Lavreys; M L Thompson; H L Martin; K Mandaliya; J O Ndinya-Achola; J J Bwayo; J Kreiss Journal: Clin Infect Dis Date: 2000-03 Impact factor: 9.079
Authors: P Vanhems; J Lambert; D A Cooper; L Perrin; A Carr; B Hirschel; J Vizzard; S Kinloch-de Loës; R Allard Journal: Clin Infect Dis Date: 1998-02 Impact factor: 9.079
Authors: Ludo Lavreys; Jared M Baeten; Varsha Chohan; R Scott McClelland; Wisal M Hassan; Barbra A Richardson; Kishorchandra Mandaliya; Jeckoniah O Ndinya-Achola; Julie Overbaugh Journal: Clin Infect Dis Date: 2006-03-27 Impact factor: 9.079
Authors: D D Panteleeff; G John; R Nduati; D Mbori-Ngacha; B Richardson; J Kreiss; J Overbaugh Journal: J Clin Microbiol Date: 1999-02 Impact factor: 5.948
Authors: François Rouet; Narcisse Elenga; Philippe Msellati; Crépin Montcho; Ida Viho; Charlotte Sakarovitch; Christine Danel; Christine Rouzioux; Valériane Leroy; François Dabis Journal: AIDS Date: 2002-11-22 Impact factor: 4.177
Authors: Raabya Rossenkhan; Vladimir Novitsky; Teresa K Sebunya; Jean Leidner; Jose E Hagan; Sikhulile Moyo; Laura Smeaton; Shahin Lockman; Rosemary Musonda; Thumbi Ndung'u; Simani Gaseitsiwe; Ibou Thior; Mompati Mmalane; Joseph Makhema; M Essex; Roger Shapiro Journal: AIDS Behav Date: 2012-07
Authors: Jennifer S Read; Anthony Mwatha; Barbra Richardson; Megan Valentine; Lynda Emel; Karim Manji; Irving Hoffman; Usha Sharma; Robert L Goldenberg; Taha E Taha Journal: J Acquir Immune Defic Syndr Date: 2009-07-01 Impact factor: 3.731
Authors: Heather B Jaspan; Landon Myer; Shabir A Madhi; Avy Violari; Diana M Gibb; Wendy S Stevens; Els Dobbels; Mark F Cotton Journal: BMC Pediatr Date: 2011-11-21 Impact factor: 2.125
Authors: Evropi Theodoratou; David A McAllister; Craig Reed; Davies O Adeloye; Igor Rudan; Lulu M Muhe; Shabir A Madhi; Harry Campbell; Harish Nair Journal: Lancet Infect Dis Date: 2014-11-12 Impact factor: 25.071
Authors: Sara Bennett; Ligia Paina; Freddie Ssengooba; Douglas Waswa; James M M'Imunya Journal: BMC Public Health Date: 2013-08-21 Impact factor: 3.295